TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4
Fig 5
Transwell cell invasion assay.
(A and B) Transwell assay was administrated in the two tumor cell lines, 48h after treatment with anti-miR-29a. When the two tumor cell lines were treated with miR-29a mimic, the migrating cells were counted after additional incubation with 5ng ml-1TGF-β1 for 48h. Data are shown as mean±SD; **P<0.01;*** P<0.001.